Indivior raises guidance on strong performance of opioid treatment
Suboxone drug has been at the centre of a US probe into its marketing (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 11, 2019 Category: Pharmaceuticals Source Type: news
New Jersey Authorizes Paramedics to Carry Buprenorphine
TRENTON (Cape May County Herald) - The State Health Commissioner June 24 authorized paramedics to carry buprenorphine to treat acute withdrawal symptoms after patients have been revived from an opioid overdose with Naloxone, the opioid overdose reversal drug.
According to a release, Commissioner Dr. Shereef Elnahal signed an Executive Directive on that date allowing the medical directors of New Jersey’s 21 Mobile Intensive Care Unit (MICU) programs to authorize paramedics to carry buprenorphine, an oral medication used to mitigate what can be severe symptoms of opioid withdrawal after a Naloxone reversal.
The MICU progra...
Source: JEMS: Journal of Emergency Medical Services News - July 3, 2019 Category: Emergency Medicine Tags: News Patient Care Administration and Leadership Source Type: news
New Jersey Authorizes Paramedics to Carry Buprenorphine
TRENTON (Cape May County Herald) - The State Health Commissioner June 24 authorized paramedics to carry buprenorphine to treat acute withdrawal symptoms after patients have been revived from an opioid overdose with Naloxone, the opioid overdose reversal drug.
According to a release, Commissioner Dr. Shereef Elnahal signed an Executive Directive on that date allowing the medical directors of New Jersey’s 21 Mobile Intensive Care Unit (MICU) programs to authorize paramedics to carry buprenorphine, an oral medication used to mitigate what can be severe symptoms of opioid withdrawal after a Naloxone reversal.
The MICU progra...
Source: JEMS Patient Care - July 3, 2019 Category: Emergency Medicine Tags: News Patient Care Administration and Leadership Source Type: news
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids - Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Eftekhari Yazdi G, Stein MD, Freedberg KA, Linas BP.
BACKGROUND: Untreated opioid use disorder (OUD) affects the care of HIV/HCV co-infected people who inject opioids. Despite active injection opioid use, there is evidence of increasing engagement in HIV care and adherence to HIV medications among HIV/HCV co... (Source: SafetyLit)
Source: SafetyLit - May 17, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions
British drugmaker Indivior Plc lost nearly three-quarters of its share value on Wednesday and former parent Reckitt Benckiser also fell following U.S. criminal charges accusing Indivior of illegally increasing prescriptions for its opioid addiction treatment Suboxone. (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
DOJ charges UK drugmaker with Suboxone fraud
Federal prosecutors with the Department of Justice have indicted Indivior for what they call a multibillion-dollar scheme to ratchet up sales of an opioid addiction treatment. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - April 10, 2019 Category: Pharmaceuticals Source Type: news
Anti-opioid addiction drug maker charged with fraud
Federal prosecutors in Virginia say the company that makes a Suboxone strips to curb opioid addiction has been lying for years about the relative safety of its product (Source: ABC News: Health)
Source: ABC News: Health - April 10, 2019 Category: Consumer Health News Tags: Health Source Type: news
Indivior shares tank after U.S. indictment for illegal marketing
Shares of Indivior Plc sank 44 percent on Wednesday after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the film version of its blockbuster opioid addiction treatment Suboxone. (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
U.S. indicts Indivior over Suboxone opioid treatment marketing
The U.S. Justice Department announced on Tuesday the indictment of Indivior Plc and a subsidiary on charges they engaged in an illegal scheme to boost prescriptions of the film version of its opioid addiction treatment Suboxone. (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
New Buprenorphine and Naloxone Sublingual Film Indicated for The Treatment of Opioid Dependence
FDA approved Buprenorphine and Naloxone Sublingual film are available in 8 mg/2 mg and 12 mg/3 mg The prescription is limited to healthcare providers who meet certain qualifying requirements Should be used as part of a complete treatment plan to include counseling and psychosocial supportThis story is related to the following:Medicinal, Pharmaceutical& Nutraceutical Tablets (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - February 25, 2019 Category: Medical Devices Source Type: news
Mylan Launches Generic Suboxone(R) Sublingual Film to Treat Opioid Dependence
HERTFORDSHIRE, England and PITTSBURGH, Feb. 22, 2019 -- (Healthcare Sales & Marketing Network) -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg and 12 mg/3 m... Biopharmaceuticals, Drug Delivery, Generics, Product Launch Mylan, Buprenorphine, Naloxone, Suboxone, Sublingual (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 22, 2019 Category: Pharmaceuticals Source Type: news
Mylan launches generic sublingual film for opioid dependence
Mylan (NSDQ:MYL) said today that it launched its buprenorphine and naloxone sublingual film as a generic of Indivior‘s (LON:INDV) Suboxone sublingual film.
The product is indicated for the treatment of opioid dependence. The therapy should be used alongside counseling and psychosocial support for people living with opioid dependence, according to Mylan.
Get the full story at our sister site, Drug Delivery Business News.
The post Mylan launches generic sublingual film for opioid dependence appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 22, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Featured Pharmaceuticals Wall Street Beat Dr. Reddy's Laboratories indivior Mylan Source Type: news
Indivior launches generic version of its Suboxone opioid drug
British drugmaker Indivior Plc said on Wednesday it had launched a copycat version of its blockbuster opioid addiction drug Suboxone in the United States, just one day after a court decision cleared the way for its rivals to market generic versions of it. (Source: Reuters: Health)
Source: Reuters: Health - February 20, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
U.S. top court rejects bid to block Indivior opioid drug copycat
The U.S. Supreme Court dealt a blow to Indivior Plc on Tuesday, clearing the way for a copycat version of the British pharmaceutical firm's lucrative opioid addiction treatment Suboxone Film in a victory for India-based generic drug maker Dr. Reddy's Laboratories. (Source: Reuters: Health)
Source: Reuters: Health - February 19, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Overdose patients at Vancouver hospital to get take-home opioid medication
Touted as a first for Canadian emergency departments, physicians at St. Paul's Hospital in Vancouver will send overdose victims home with enough Suboxone for three days of treatment. (Source: CBC | Health)
Source: CBC | Health - February 7, 2019 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news
